ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Tiny Health Appoints Dr. Elisa Song as Chief Medical Officer and Dr. Taylor Sittler as Board Director

AUSTIN, Texas, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Tiny Health, a pioneer in at-home microbiome testing for babies and families, announces the addition of two esteemed physicians to its leadership team: Dr. Elisa Song as Chief Medical Officer and Dr. Taylor Sittler as Board Director.

These appointments come as Tiny Health accelerates its clinical research, announces groundbreaking new scientific capabilities, and deepens its engagement with health practitioners—all in an effort to empower families and reduce risks of chronic conditions that affect nearly 1 in 2 children in the U.S.

Dr. Elisa Song is a renowned Stanford-, NYU-, UCSF-trained integrative pediatrician with over 25 years of clinical experience and a strong commitment to holistic care to heal the root causes of sickness which often lie in the gut microbiome. Having served as Tiny Health's Medical Advisor since June 2023, she was instrumental in developing the company's clinical-grade PRO Gut Health Test.

Elisa Song, MD - Tiny Health Chief Medical Officer

“I am honored to step into the role of Chief Medical Officer,” said Dr. Song. “Chronic conditions are on the rise, and Tiny Health is equipping practitioners with cutting-edge microbiome science to meet the moment. By empowering families with practical, actionable microbiome insights, I believe we can make a real difference in children's health outcomes.”

Dr. Taylor Sittler is a UMass- and UCSF-trained and Board-Certified Pathologist, serial entrepreneur, and angel investor in Tiny Health. He is a pioneer in genetics through his work at Color Genomics, women's health at The Cusp, and metabolic health monitoring at Levels Health. He is passionate about using technology and machine learning to transform medical practice.

Dr. Taylor Sittler - Tiny Health Independent Board Director

“Tiny Health has built the highest quality platform for assessment of the microbiome, an important emerging modality in root cause evaluation, particularly for young children and their families,” Dr. Sittler said. “I’m excited to join Tiny Health’s board at a time when the company is poised to deepen its impact in the clinical space.”

Since announcing its partnership with Rupa Health in June, Tiny Health's network has grown to over 1,000 health practitioners, with new clinicians joining every month to integrate the most advanced gut and vaginal testing available into their standard of care. The company is committed to educating and empowering families to address the root cause of chronic conditions that are often related to gut health functions, from the critical first 1,000 days of life through adulthood.

“We’re excited to welcome Dr. Song and Dr. Sittler to the Tiny Health family,” said Cheryl Sew Hoy, Founder and CEO of Tiny Health. “Their expertise in conventional and integrative medicine is invaluable as we continue to innovate and expand. With our upcoming publication focused on C-section babies and new research initiatives with UCSF, their leadership strengthens our position as a trusted partner for practitioners and parents alike.”

As highlighted in a recent Washington Post article, Tiny Health is meeting a growing need for deeper insights through its microbiome tests, helping families who haven't found answers through conventional means. With Dr. Song and Dr. Sittler's leadership, Tiny Health is well-positioned to educate parents and practitioners on the gut-immune axis’s role in preventing, reversing, and managing chronic conditions.

In tandem with these leadership announcements, Tiny Health has introduced Pathogen Strain Tracking and Bacterial Toxin Genes capabilities to their tests, providing unparalleled detail in identifying and monitoring gut pathogens.

Tiny Health Gut Health Test with PRO PDF

“No other stool testing technology offers this level of resolution,” said Cheryl Sew Hoy. “Our reports empower practitioners with the ability to distinguish between benign and pathogenic strains. By empowering them with data and critical clinical insights into bacterial activities, we hope to help them make more informed decisions and tailor interventions for their patients with greater precision.”

To learn how Tiny Health works with practitioners and digital health innovators to deliver better care and advance microbiome health, visit PoweredByTiny.com.

About Tiny Health:

Founded in 2020, Tiny Health is the first-ever at-home gut microbiome test developed for babies, empowering families to take control of their gut health to improve long-term health outcomes. Built by a team of microbiome scientists and early-life experts, our innovative tests educate consumers about the microbes in their bodies and provide evidence-based interventions to optimize overall well-being. Serving 25,000+ families across the U.S., Tiny Health offers gut health testing for every stage of life – from the womb through adulthood. For more information and to try out Tiny Health, visit tinyhealth.com.

Contact:

Hannah Goering
Tiny Health
press@tinyhealth.com

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/887ce4a8-6485-4ff3-81e2-c5db441093f5

https://www.globenewswire.com/NewsRoom/AttachmentNg/27547a40-1bd1-45c6-9bbf-f705e4d3c7db

https://www.globenewswire.com/NewsRoom/AttachmentNg/ee2c19df-ef55-46ab-b5df-ea4161c620b3


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.56
+0.02 (0.01%)
AAPL  274.61
+0.50 (0.18%)
AMD  209.17
+1.59 (0.77%)
BAC  54.81
-0.52 (-0.94%)
GOOG  307.73
-1.59 (-0.51%)
META  657.15
+9.64 (1.49%)
MSFT  476.39
+1.57 (0.33%)
NVDA  177.72
+1.43 (0.81%)
ORCL  188.65
+3.73 (2.02%)
TSLA  489.88
+14.57 (3.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.